AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.53 Cr | ₹-2.95 Cr | ₹9.09 Cr | ₹-19 Cr | ₹-5.84 Cr |
What is the latest Cash Flow from Financing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.53 Cr |
| Mar2024 | ₹-2.95 Cr |
| Mar2023 | ₹9.09 Cr |
| Mar2022 | ₹-19 Cr |
| Mar2021 | ₹-5.84 Cr |
How is Cash Flow from Financing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.53 Cr | Negative | |
| Mar2024 | ₹-2.95 Cr | Negative | |
| Mar2023 | ₹9.09 Cr | Positive | |
| Mar2022 | ₹-19 Cr | Negative | |
| Mar2021 | ₹-5.84 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹217.5 Cr | 10.3% | -3.3% | -45.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 10.3% |
-3.3% |
-45.1% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses